Cardiomyopathy of Friedreich's ataxia: Use of mouse models to understand human disease and guide therapeutic development

R. Payne, P. Melanie Pride, Clifford M. Babbey

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Friedreich's ataxia is a multisystem disorder of mitochondrial function affecting primarily the heart and brain. Patients experience a severe cardiomyopathy that can progress to heart failure and death. Although the gene defect is known, the precise function of the deficient mitochondrial protein, frataxin, is not known and limits therapeutic development. Animal models have been valuable for understanding the basic events of this disease. A significant need exists to focus greater attention on the heart disease in Friedreich's ataxia, to understand its long-term outcome, and to develop new therapeutic strategies using existing medications and approaches. This review discusses some key features of the cardiomyopathy in Friedreich's ataxia and potential therapeutic developments.

Original languageEnglish
Pages (from-to)366-378
Number of pages13
JournalPediatric Cardiology
Volume32
Issue number3
DOIs
StatePublished - Mar 2011

Fingerprint

Friedreich Ataxia
Cardiomyopathies
Mitochondrial Diseases
Mitochondrial Proteins
Heart Diseases
Therapeutics
Animal Models
Heart Failure
Brain
Genes

Keywords

  • Cardiomyopathy
  • Friedreich's ataxia
  • Mitochondria
  • Therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Cardiomyopathy of Friedreich's ataxia : Use of mouse models to understand human disease and guide therapeutic development. / Payne, R.; Pride, P. Melanie; Babbey, Clifford M.

In: Pediatric Cardiology, Vol. 32, No. 3, 03.2011, p. 366-378.

Research output: Contribution to journalArticle

@article{043ede63c0284a878787b50707e198d4,
title = "Cardiomyopathy of Friedreich's ataxia: Use of mouse models to understand human disease and guide therapeutic development",
abstract = "Friedreich's ataxia is a multisystem disorder of mitochondrial function affecting primarily the heart and brain. Patients experience a severe cardiomyopathy that can progress to heart failure and death. Although the gene defect is known, the precise function of the deficient mitochondrial protein, frataxin, is not known and limits therapeutic development. Animal models have been valuable for understanding the basic events of this disease. A significant need exists to focus greater attention on the heart disease in Friedreich's ataxia, to understand its long-term outcome, and to develop new therapeutic strategies using existing medications and approaches. This review discusses some key features of the cardiomyopathy in Friedreich's ataxia and potential therapeutic developments.",
keywords = "Cardiomyopathy, Friedreich's ataxia, Mitochondria, Therapy",
author = "R. Payne and Pride, {P. Melanie} and Babbey, {Clifford M.}",
year = "2011",
month = "3",
doi = "10.1007/s00246-011-9943-6",
language = "English",
volume = "32",
pages = "366--378",
journal = "Pediatric Cardiology",
issn = "0172-0643",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Cardiomyopathy of Friedreich's ataxia

T2 - Use of mouse models to understand human disease and guide therapeutic development

AU - Payne, R.

AU - Pride, P. Melanie

AU - Babbey, Clifford M.

PY - 2011/3

Y1 - 2011/3

N2 - Friedreich's ataxia is a multisystem disorder of mitochondrial function affecting primarily the heart and brain. Patients experience a severe cardiomyopathy that can progress to heart failure and death. Although the gene defect is known, the precise function of the deficient mitochondrial protein, frataxin, is not known and limits therapeutic development. Animal models have been valuable for understanding the basic events of this disease. A significant need exists to focus greater attention on the heart disease in Friedreich's ataxia, to understand its long-term outcome, and to develop new therapeutic strategies using existing medications and approaches. This review discusses some key features of the cardiomyopathy in Friedreich's ataxia and potential therapeutic developments.

AB - Friedreich's ataxia is a multisystem disorder of mitochondrial function affecting primarily the heart and brain. Patients experience a severe cardiomyopathy that can progress to heart failure and death. Although the gene defect is known, the precise function of the deficient mitochondrial protein, frataxin, is not known and limits therapeutic development. Animal models have been valuable for understanding the basic events of this disease. A significant need exists to focus greater attention on the heart disease in Friedreich's ataxia, to understand its long-term outcome, and to develop new therapeutic strategies using existing medications and approaches. This review discusses some key features of the cardiomyopathy in Friedreich's ataxia and potential therapeutic developments.

KW - Cardiomyopathy

KW - Friedreich's ataxia

KW - Mitochondria

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=79953753153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953753153&partnerID=8YFLogxK

U2 - 10.1007/s00246-011-9943-6

DO - 10.1007/s00246-011-9943-6

M3 - Article

C2 - 21360265

AN - SCOPUS:79953753153

VL - 32

SP - 366

EP - 378

JO - Pediatric Cardiology

JF - Pediatric Cardiology

SN - 0172-0643

IS - 3

ER -